Calcyclin-binding protein contributes to cholangiocarcinoma progression by inhibiting ubiquitination of MCM2
Sign Up to like & getrecommendations! Published in 2023 at "Oncology Research"
DOI: 10.32604/or.2023.028418
Abstract: Background: Cholangiocarcinoma (CCA) represents the epithelial cell cancer with high aggressiveness whose five-year survival rate is poor with standard treatment. Calcyclin-binding protein (CACYBP) shows aberrant expression within several malignant tumors, but the role of CACYBP… read more here.
Keywords: ubiquitination mcm2; binding protein; cell; cca ... See more keywords